Elevated SOCS Gene Expression in Breast Cancer
Author Information
Author(s): Raccurt M, Tam S P, Lau P, Mertani H C, Lambert A, Garcia-Caballero T, Li H, Brown R J, McGuckin M A, Morel G, Waters M J
Primary Institution: Université Claude Bernard-Lyon 1
Hypothesis
The study examines the expression of suppressor of cytokine signaling (SOCS) genes in breast cancer tissues and cell lines.
Conclusion
The study found that SOCS-1, -2, -3, and CIS mRNA levels are significantly elevated in breast cancer tissues compared to normal tissues.
Supporting Evidence
- SOCS-1 gene expression increased in cancerous ducts by 22% compared to normal ducts.
- SOCS-2 gene expression increased by 135% in cancerous cells of in situ ductal carcinoma.
- SOCS-3 gene expression increased by 32% in cancerous ducts compared to normal ducts.
- CIS gene expression was elevated by 120% in tumor cells of in situ ductal carcinoma.
Takeaway
This study looked at how certain genes that help control cell growth are more active in breast cancer, which might help us understand how the disease works.
Methodology
The study analyzed surgical samples of breast cancer and breast cancer cell lines using in situ hybridization and immunohistochemistry to measure SOCS gene expression.
Potential Biases
Potential bias may arise from the selection of tissue samples and the methods used for gene expression analysis.
Limitations
The study is limited by the small sample size and the focus on specific types of breast cancer.
Participant Demographics
The study included 20 human breast samples, with varying stages of cancer.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website